Transforming Drug Discovery with Autonomous Agents
Merck and Google Cloud Sign $1 Billion Agentic AI Deal
The multi-year partnership aims to accelerate drug discovery and manufacturing through autonomous AI agents.
A scientist in a high-tech lab monitors digital displays of molecular structures, representing the integration of AI in pharmaceutical research.
Photo: Avantgarde News
Merck and Google Cloud announced a multi-year partnership valued at up to $1 billion [1][2]. The collaboration focuses on deploying "agentic AI" across Merck's research and development, manufacturing, and commercial operations [1]. These autonomous AI systems are designed to accelerate scientific breakthroughs and drug discovery processes [1][3].
The deal marks a significant investment in pharmaceutical technology [2]. Merck plans to use Google Cloud’s infrastructure to streamline its global supply chain and internal workflows [1]. By integrating these AI agents, the company hopes to shorten the time required to bring new treatments to market [1][3].
Editorial notes
Transparency note
AI assisted drafting. Human edited and reviewed.
- AI assisted
- Yes
- Human review
- Yes
- Last updated
Risk assessment
Reviewed for sourcing quality and editorial consistency.
Sources
- 1.↗
merck.com
https://www.merck.com/news/merck-and-google-cloud-partner-to-accelerate-agentic-ai-enterprise-transformation/
- 2.↗
investing.com
https://www.investing.com/news/company-news/merck-partners-with-google-cloud-in-1-billion-ai-deal-93CH-4629063
- 3.↗
pharmalive.com
https://www.pharmalive.com/merck-to-partner-with-google-cloud-on-ai-initiatives/
Related stories
View all
Topics
About the author
Avantgarde News Desk covers transforming drug discovery with autonomous agents and editorial analysis for Avantgarde News.